MENU
ZA | ZAR
ZA | ZAR
-
- Benchtop Centrifuges
- Floor-Standing Centrifuges
- Refrigerated Centrifuges
- Microcentrifuges
- Multipurpose Centrifuges
- High-Speed Centrifuges
- Ultracentrifuges
- Concentrator
- High-Speed and Ultracentrifugation Consumables
- Accessories
- Tubes
- Plates
- Device Management Software
- Sample and Information Management
You are about to leave this site.
Please be aware that your current cart is not saved yet and cannot be restored on the new site nor when you come back. If you want to save your cart please login in into your account.
myEppendorf
No results found
Search Suggestions
Webinar
Breaking Boundaries in Process Development: Unleashing the Power of Stirred-Tank Bioreactors for Cell and Gene Therapies
Lab Academy
- Bioprocessing
- Lab Life
- Bioprocess
- Recorded Webinars
The field of cell and gene therapy has enjoyed spectacular growth in recent years and is destined to be one of the strongest growing markets in the biopharmaceutical industry. More than 20 approved gene therapies are already on the market, providing potentially life-saving treatment options for patients with rare diseases. Manufacturing these novel therapies requires a continual supply of billions of cells, generated by robust, scalable, and economically viable bioprocesses.
In this regard, stirred-tank bioreactors have emerged as the optimal platform to optimize (stem) cell culturing to optimize process development. While facing similar challenges as encountered by the traditional biologics industry, the cell and gene therapy industry can benefit from those lessons. This community will benefit from the successful transfer of knowledge and best practices in terms of scalability, single-use technologies, and the overall benefits of moving to stirred-tank bioreactor systems. In this webinar, experts from industry and academia will share their insights and experiences as they lay out the potential of stirred-tank bioreactors for cell and gene therapy development and manufacturing.
Key Learning Objectives:
Speakers:
Dr. Philipp Nold, Eppendorf SE
Dr. Robert Zweigerdt, MHH
Lior Raviv, Pluri Inc.
Duration:
90 min
Key Learning Objectives:
- Advances in commercializing cell and gene therapy development
- The key role of stirred-tank bioreactors from research to manufacturing
- How to bring life-saving cell and gene therapies to market
Speakers:
Dr. Philipp Nold, Eppendorf SE
Dr. Robert Zweigerdt, MHH
Lior Raviv, Pluri Inc.
Duration:
90 min
Read more
Read less